More and more people are starting to decry the lack of progress from AI-driven companies that promised large numbers of drugs would come to market by now. And what they've produced is neither novel nor performing well in clinical trials.
Diagnosed with small-cell lung cancer on Labor Day of 2016, he immediately underwent all available conventional treatments and was eventually told to "hire Hospice." Curious and unafraid, he utilized information from a mouse study and is now "NED" -
Publisher Recommended Casey Means was a Stanford-educated surgeon. Her brother Calley was a lobbyist for pharma and the food industry. Both quit their jobs in horror when they realized how many people were being killed by the systems they part
In a medical emergency, quick treatment is critical. But a widely used drug could be repurposed to induce a hibernation-like state, to slow down organ damage and save lives by giving patients more time to reach a hospital.
American medicine excels in treating trauma. So, if you get hit by a car, are in a fire, fall off a ladder, or are shot, you can expect help at a hospital. However, American medicine is failing in chronic disease.
The American Board of Internal Medicine last week revoked the certifications of Drs. Pierre Kory and Paul Marik, following a two-year investigation into their promotion of ivermectin and hydroxychloroquine as treatments for COVID-19 and their stateme
A drug used to induce labor in pregnant women has been shown to reactivate tiny waste-clearing pumps in the brains of old mice. The finding could hold promise as a new way to fight Alzheimer's and Parkinson's diseases and overall cognitive decline.
Despite the reports of cheap and readily available ivermectin being successfully used to treat patients, it posed a threat to the pharmaceutical industry's Covid mRNA shots and the profits from pushing the injections onto the public.
A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research from the University of Illinois Chicago.
An increase in cancer cases is putting pressure on Americans already facing a difficult situation--exorbitant drug prices, a lack of regulation, and a system that seems designed to profit, according to experts.